The Biotech Balancing Act: Long-Term Vision Vs. Inflection Points

Tuyen Ong, a CEO-partner at Flagship Pioneering and CEO of Ring Therapeutics, discusses the importance of balancing short-term wins with a longer-term vision when building a biotech.